CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Articles

  • Articles
  • Pacients
  • Researchers
  • ATMPs
  • GMP
  • Laboratory
  • Manufacturing Process
  • Pre Clinical
  • UMCUtrecht
  • Rodrigo Ortiz
9 December 2025

Bridging the Gap: The Role of GMP Simulation in ATMP Translation

In recent decades, the medical toolbox has expanded dramatically. While traditional medicine relied on synthetic drugs (small molecules interacting with specific pathways) and later biologicals like antibodies, we have now entered the era of ...

  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 September 2025

From Film Editing to RNA Editing: How RNA Trans-splicing Could Treat CTNNB1 Syndrome

Imagine you're in a movie editing studio, trying to fix a film with some corrupted scenes. The film is vital, as it plays a crucial role in the development and function of an entire ...

Trans Splicing Paper
  • Articles
  • Clinicians
  • Pacients
  • Clinic study
  • Regulation
  • CTGCT
  • NIC
  • Gregor Cuzak
16 July 2025

CTIS public portal – a great tool for finding and exploring clinical trials in Europe

The Clinical Trials Information System (CTIS) public portal is a new European tool that allows anyone to access information about clinical trials taking place in the European Union (EU) and European Economic Area (EEA). ...

  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Research
  • Rodrigo Ortiz
5 June 2025

Unraveling the Mysteries of NLRP3: A Key Player in Inflammation

In the complex world of cellular biology, proteins play a crucial role in maintaining our body's health and responding to threats. One such protein, NLRP3, is known for its ability to assemble the inflammasome ...

Nlrp3 Paper
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
3 June 2025

Harnessing Synthetic Biology for Innovative Medical Treatments

In the world of synthetic biology, scientists are pushing the boundaries of what's possible by designing proteins that can be controlled in specific ways. This review written by Tjaša Plaper, Urška Knez Štibler and ...

Synthetic biology Review
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 May 2025

How Ultrasound Can Control Cells, the Future of Medicine?

Members of our team have already published work on sonogenetics (check our article breaking down that research here). We think this could have interesting applications in the future, since it overcomes the issue of ...

Review Sonogenetics
  • Articles
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Raziskave
  • CTGCT
  • NIC
  • Rodrigo Ortiz
8 April 2025 Event Date: 21 March 2025 do: 21 March 2025 •

CTGCT’s Role in the GeneH Project: Accelerating Gene Therapy Innovations

We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ...

  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 February 2025

Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy

Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ...

Graphical Abstract Controlling Cells
  • Articles
  • Pacients
  • CTGCT
  • Gregor Cuzak
18 February 2025

Hugs for rare

The 28th of February is approaching which is the Day of Rare diseases. Hugs are being collected in 7 countries to raise awareness of the importance of everyone working together to defeat rare diseases.

Hugs1
  • Articles
  • Pacients
  • Research
  • CTGCT
11 February 2025

Women at CTGCT: Voices from the Lab

Today we we celebrate the International Day of Women and Girls in Science, we take a moment to spotlight the women working at the Centre for the Technologies of Gene and Cell Therapy (CTGCT)

Women In Science Cover, image generated using AI, Dall-e

Posts pagination

1 2

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2026
Website production: Kreativna tovarna